{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:41:03Z","timestamp":1762101663368,"version":"build-2065373602"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T00:00:00Z","timestamp":1708473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T00:00:00Z","timestamp":1708473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2017MH069"],"award-info":[{"award-number":["ZR2017MH069"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-024-03958-1","type":"journal-article","created":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T13:02:38Z","timestamp":1708520558000},"page":"2351-2361","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The effect of metabolic factors on the association between hyperuricemia and chronic kidney disease: a retrospective cohort mediation analysis"],"prefix":"10.1007","volume":"56","author":[{"given":"Hua","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuo","family":"Geng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Libo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengmeng","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingzi","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6806-5906","authenticated-orcid":false,"given":"Wenshan","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,2,21]]},"reference":[{"issue":"2","key":"3958_CR1","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/bor.0000000000000028","volume":"26","author":"T Bardin","year":"2014","unstructured":"Bardin T, Richette P (2014) Definition of hyperuricemia and gouty conditions. Curr Opin Rheumatol 26(2):186\u2013191. https:\/\/doi.org\/10.1097\/bor.0000000000000028","journal-title":"Curr Opin Rheumatol"},{"key":"3958_CR2","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/762820","volume":"2015","author":"R Liu","year":"2015","unstructured":"Liu R, Han C, Wu D et al (2015) Prevalence of hyperuricemia and Gout in Mainland China from 2000 to 2014: a systematic review and meta-analysis. Biomed Res Int 2015:762820. https:\/\/doi.org\/10.1155\/2015\/762820","journal-title":"Biomed Res Int"},{"issue":"10","key":"3958_CR3","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1038\/sj.ki.5000391","volume":"69","author":"T Nakagawa","year":"2006","unstructured":"Nakagawa T, Kang DH, Feig D et al (2006) Unearthing uric acid: an ancient factor with recently found significance in renal and cardiovascular disease. Kidney Int 69(10):1722\u20131725. https:\/\/doi.org\/10.1038\/sj.ki.5000391","journal-title":"Kidney Int"},{"issue":"18","key":"3958_CR4","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1001\/jama.283.18.2404","volume":"283","author":"J Fang","year":"2000","unstructured":"Fang J, Alderman MH (2000) Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971\u20131992. National Health and Nutrition Examination Survey. JAMA 283(18):2404\u20132410. https:\/\/doi.org\/10.1001\/jama.283.18.2404","journal-title":"JAMA"},{"issue":"11","key":"3958_CR5","doi-asserted-by":"publisher","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","volume":"158","author":"PE Stevens","year":"2013","unstructured":"Stevens PE, Levin A (2013) Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med 158(11):825\u2013830. https:\/\/doi.org\/10.7326\/0003-4819-158-11-201306040-00007","journal-title":"Ann Intern Med"},{"issue":"3","key":"3958_CR6","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/sj.ki.5002343","volume":"72","author":"AS Levey","year":"2007","unstructured":"Levey AS, Atkins R, Coresh J et al (2007) Chronic kidney disease as a global public health problem: approaches and initiatives\u2014a position statement from Kidney Disease Improving Global Outcomes. Kidney Int 72(3):247\u2013259. https:\/\/doi.org\/10.1038\/sj.ki.5002343","journal-title":"Kidney Int"},{"issue":"10105","key":"3958_CR7","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/s0140-6736(17)30788-2","volume":"390","author":"A Levin","year":"2017","unstructured":"Levin A, Tonelli M, Bonventre J et al (2017) Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy. Lancet (London, England) 390(10105):1888\u20131917. https:\/\/doi.org\/10.1016\/s0140-6736(17)30788-2","journal-title":"Lancet (London, England)"},{"issue":"6","key":"3958_CR8","doi-asserted-by":"publisher","first-page":"F991","DOI":"10.1152\/ajprenal.00283.2001","volume":"282","author":"M Mazzali","year":"2002","unstructured":"Mazzali M, Kanellis J, Han L et al (2002) Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol 282(6):F991\u2013F997. https:\/\/doi.org\/10.1152\/ajprenal.00283.2001","journal-title":"Am J Physiol Renal Physiol"},{"issue":"1","key":"3958_CR9","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/j.1523-1755.2005.00074.x","volume":"67","author":"LG S\u00e1nchez-Lozada","year":"2005","unstructured":"S\u00e1nchez-Lozada LG, Tapia E, Santamar\u00eda J et al (2005) Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats. Kidney Int 67(1):237\u2013247. https:\/\/doi.org\/10.1111\/j.1523-1755.2005.00074.x","journal-title":"Kidney Int"},{"issue":"3\u20134","key":"3958_CR10","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1159\/000345509","volume":"121","author":"LG S\u00e1nchez-Lozada","year":"2012","unstructured":"S\u00e1nchez-Lozada LG, Lanaspa MA, Crist\u00f3bal-Garc\u00eda M et al (2012) Uric acid-induced endothelial dysfunction is associated with mitochondrial alterations and decreased intracellular ATP concentrations. Nephron Exp Nephrol 121(3\u20134):e71\u2013e78. https:\/\/doi.org\/10.1159\/000345509","journal-title":"Nephron Exp Nephrol"},{"issue":"12","key":"3958_CR11","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1097\/01.asn.0000034910.58454.fd","volume":"13","author":"DH Kang","year":"2002","unstructured":"Kang DH, Nakagawa T, Feng L et al (2002) A role for uric acid in the progression of renal disease. J Am Soc Nephrol 13(12):2888\u20132897. https:\/\/doi.org\/10.1097\/01.asn.0000034910.58454.fd","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"3958_CR12","doi-asserted-by":"publisher","first-page":"6681","DOI":"10.1038\/s41598-019-43241-3","volume":"9","author":"TR Oh","year":"2019","unstructured":"Oh TR, Choi HS, Kim CS et al (2019) Hyperuricemia has increased the risk of progression of chronic kidney disease: propensity score matching analysis from the KNOW-CKD study. Sci Rep 9(1):6681. https:\/\/doi.org\/10.1038\/s41598-019-43241-3","journal-title":"Sci Rep"},{"issue":"2","key":"3958_CR13","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1093\/ndt\/gft378","volume":"29","author":"B Bose","year":"2014","unstructured":"Bose B, Badve SV, Hiremath SS et al (2014) Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis. Nephrol Dial Transplant 29(2):406\u2013413. https:\/\/doi.org\/10.1093\/ndt\/gft378","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"3958_CR14","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s40620-020-00702-7","volume":"33","author":"B Bonino","year":"2020","unstructured":"Bonino B, Leoncini G, Russo E, Pontremoli R, Viazzi F (2020) Uric acid in CKD: has the jury come to the verdict? J Nephrol 33(4):715\u2013724. https:\/\/doi.org\/10.1007\/s40620-020-00702-7","journal-title":"J Nephrol"},{"key":"3958_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9040942","author":"M Kuwabara","year":"2020","unstructured":"Kuwabara M, Hisatome I, Niwa K et al (2020) The optimal range of serum uric acid for cardiometabolic diseases: a 5-year japanese cohort study. J Clin Med. https:\/\/doi.org\/10.3390\/jcm9040942","journal-title":"J Clin Med"},{"issue":"6","key":"3958_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0100801","volume":"9","author":"P Zhu","year":"2014","unstructured":"Zhu P, Liu Y, Han L, Xu G, Ran JM (2014) Serum uric acid is associated with incident chronic kidney disease in middle-aged populations: a meta-analysis of 15 cohort studies. PLoS ONE 9(6):e100801. https:\/\/doi.org\/10.1371\/journal.pone.0100801","journal-title":"PLoS ONE"},{"issue":"1","key":"3958_CR17","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1080\/0886022x.2018.1456463","volume":"40","author":"X Liu","year":"2018","unstructured":"Liu X, Zhai T, Ma R, Luo C, Wang H, Liu L (2018) Effects of uric acid-lowering therapy on the progression of chronic kidney disease: a systematic review and meta-analysis. Ren Fail 40(1):289\u2013297. https:\/\/doi.org\/10.1080\/0886022x.2018.1456463","journal-title":"Ren Fail"},{"issue":"4","key":"3958_CR18","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1093\/ndt\/gfm790","volume":"23","author":"RP Obermayr","year":"2008","unstructured":"Obermayr RP, Temml C, Knechtelsdorfer M et al (2008) Predictors of new-onset decline in kidney function in a general middle-european population. Nephrol Dial Transplant 23(4):1265\u20131273. https:\/\/doi.org\/10.1093\/ndt\/gfm790","journal-title":"Nephrol Dial Transplant"},{"key":"3958_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.702138","volume":"12","author":"L Xu","year":"2021","unstructured":"Xu L, Sun H, Liu L et al (2021) The effects of cardiometabolic factors on the association between serum uric acid and chronic kidney disease in chinese middle-aged and older population: a mediation analysis. Front Endocrinol 12:702138. https:\/\/doi.org\/10.3389\/fendo.2021.702138","journal-title":"Front Endocrinol"},{"key":"3958_CR20","unstructured":"CMA CSoE. Chinese guidelines for the diagnosis and treatment of hyperuricaemia and gout (2019). Chin J Endocrinol Metab. 2020;(01):1\u201313."},{"issue":"9","key":"3958_CR21","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150(9):604\u2013612. https:\/\/doi.org\/10.7326\/0003-4819-150-9-200905050-00006","journal-title":"Ann Intern Med"},{"key":"3958_CR22","doi-asserted-by":"publisher","first-page":"818836","DOI":"10.3389\/fnut.2022.818836","volume":"9","author":"Y Shi","year":"2022","unstructured":"Shi Y, Wu Z, Wu J, Chen Z, Li P (2022) Serum homocysteine level is positively correlated with serum uric acid level in U.S. adolescents: a cross sectional study. Front Nutr 9:818836. https:\/\/doi.org\/10.3389\/fnut.2022.818836","journal-title":"Front Nutr"},{"key":"3958_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejim.2020.07.006","volume":"80","author":"C Borghi","year":"2020","unstructured":"Borghi C, Agabiti-Rosei E, Johnson RJ et al (2020) Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease. Eur J Intern Med 80:1\u201311. https:\/\/doi.org\/10.1016\/j.ejim.2020.07.006","journal-title":"Eur J Intern Med"},{"key":"3958_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.964101","volume":"9","author":"YL Shih","year":"2022","unstructured":"Shih YL, Shih CC, Chen JY (2022) Elevated homocysteine level as an indicator for chronic kidney disease in community-dwelling middle-aged and elderly populations in Taiwan: a community-based cross-sectional study. Front Med 9:964101. https:\/\/doi.org\/10.3389\/fmed.2022.964101","journal-title":"Front Med"},{"issue":"1","key":"3958_CR25","doi-asserted-by":"publisher","first-page":"5001","DOI":"10.1038\/s41598-023-32279-z","volume":"13","author":"S Kawasoe","year":"2023","unstructured":"Kawasoe S, Kubozono T, Salim AA et al (2023) Development of a risk prediction score and equation for chronic kidney disease: a retrospective cohort study. Sci Rep 13(1):5001. https:\/\/doi.org\/10.1038\/s41598-023-32279-z","journal-title":"Sci Rep"},{"issue":"3","key":"3958_CR26","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s11255-017-1732-6","volume":"50","author":"X Cao","year":"2018","unstructured":"Cao X, Wu L, Chen Z (2018) The association between elevated serum uric acid level and an increased risk of renal function decline in a health checkup cohort in China. Int Urol Nephrol 50(3):517\u2013525. https:\/\/doi.org\/10.1007\/s11255-017-1732-6","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"3958_CR27","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s12882-018-0982-6","volume":"19","author":"M Ye","year":"2018","unstructured":"Ye M, Hu K, Jin J, Wu D, Hu P, He Q (2018) The association between time-mean serum uric acid levels and the incidence of chronic kidney disease in the general population: a retrospective study. BMC Nephrol 19(1):190. https:\/\/doi.org\/10.1186\/s12882-018-0982-6","journal-title":"BMC Nephrol"},{"issue":"Suppl","key":"3958_CR28","first-page":"1","volume":"17","author":"C Chen","year":"2004","unstructured":"Chen C, Lu FC (2004) The guidelines for prevention and control of overweight and obesity in Chinese adults. Biomed Environ Sci 17(Suppl):1\u201336","journal-title":"Biomed Environ Sci"},{"issue":"2","key":"3958_CR29","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1152\/advan.00018.2018","volume":"42","author":"D Curran-Everett","year":"2018","unstructured":"Curran-Everett D (2018) Explorations in statistics: the log transformation. Adv Physiol Educ 42(2):343\u2013347. https:\/\/doi.org\/10.1152\/advan.00018.2018","journal-title":"Adv Physiol Educ"},{"key":"3958_CR30","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1146\/annurev-publhealth-032315-021402","volume":"37","author":"TJ VanderWeele","year":"2016","unstructured":"VanderWeele TJ (2016) Mediation analysis: a practitioner\u2019s guide. Annu Rev Public Health 37:17\u201332. https:\/\/doi.org\/10.1146\/annurev-publhealth-032315-021402","journal-title":"Annu Rev Public Health"},{"issue":"04","key":"3958_CR31","first-page":"120","volume":"9","author":"R Chen","year":"2013","unstructured":"Chen R, Zheng Y, Liu W (2013) Mediated effects analysis: principles, procedures, bootstrap methods, and applications. J Market Sci 9(04):120\u2013135","journal-title":"J Market Sci"},{"issue":"1","key":"3958_CR32","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc Ser B (Methodol) 57(1):289\u2013300","journal-title":"J Roy Stat Soc Ser B (Methodol)"},{"issue":"4","key":"3958_CR33","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1037\/1082-989X.7.4.422","volume":"7","author":"PE Shrout","year":"2002","unstructured":"Shrout PE, Bolger N (2002) Mediation in experimental and nonexperimental studies: new procedures and recommendations. Psychol Methods 7(4):422\u2013445","journal-title":"Psychol Methods"},{"issue":"16\u201317","key":"3958_CR34","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/j.clinbiochem.2012.05.031","volume":"45","author":"CC Wu","year":"2012","unstructured":"Wu CC, Zheng CM, Lin YF, Lo L, Liao MT, Lu KC (2012) Role of homocysteine in end-stage renal disease. Clin Biochem 45(16\u201317):1286\u20131294. https:\/\/doi.org\/10.1016\/j.clinbiochem.2012.05.031","journal-title":"Clin Biochem"},{"issue":"3","key":"3958_CR35","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1097\/jim.0000000000000152","volume":"63","author":"E Cohen","year":"2015","unstructured":"Cohen E, Levi A, Vecht-Lifshitz SE, Goldberg E, Garty M, Krause I (2015) Assessment of a possible link between hyperhomocysteinemia and hyperuricemia. J Invest Med 63(3):534\u2013538. https:\/\/doi.org\/10.1097\/jim.0000000000000152","journal-title":"J Invest Med"},{"issue":"1","key":"3958_CR36","doi-asserted-by":"publisher","first-page":"17401","DOI":"10.1038\/s41598-020-74596-7","volume":"10","author":"R Xu","year":"2020","unstructured":"Xu R, Huang F, Wang Y, Liu Q, Lv Y, Zhang Q (2020) Gender- and age-related differences in homocysteine concentration: a cross-sectional study of the general population of China. Sci Rep 10(1):17401. https:\/\/doi.org\/10.1038\/s41598-020-74596-7","journal-title":"Sci Rep"},{"key":"3958_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19124116","author":"MY Lee","year":"2018","unstructured":"Lee MY, Huang JC, Chen SC, Chiou HC, Wu PY (2018) Association of HbA(1C) variability and renal progression in patients with type 2 diabetes with chronic kidney disease stages 3-4. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms19124116","journal-title":"Int J Mol Sci"},{"issue":"4","key":"3958_CR38","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1161\/hypertensionaha.119.13422","volume":"74","author":"EH Bae","year":"2019","unstructured":"Bae EH, Lim SY, Han KD et al (2019) Association between systolic and diastolic blood pressure variability and the risk of end-stage renal disease. Hypertension (Dallas, Tex\u202f: 1979) 74(4):880\u2013887. https:\/\/doi.org\/10.1161\/hypertensionaha.119.13422","journal-title":"Hypertension (Dallas, Tex : 1979)"},{"key":"3958_CR39","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ejim.2023.02.019","volume":"111","author":"R Pontremoli","year":"2023","unstructured":"Pontremoli R, Desideri G, Arca M et al (2023) Hypertriglyceridemia is associated with decline of estimated glomerular filtration rate and risk of end-stage kidney disease in a real-word Italian cohort: evidence from the TG-RENAL Study. Eur J Intern Med 111:90\u201396. https:\/\/doi.org\/10.1016\/j.ejim.2023.02.019","journal-title":"Eur J Intern Med"},{"issue":"3","key":"3958_CR40","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/S0021-9258(18)70253-6","volume":"234","author":"G De La Haba","year":"1959","unstructured":"De La Haba G, Cantoni GL (1959) The enzymatic synthesis of S-adenosyl-L-homocysteine from adenosine and homocysteine. J Biol Chem 234(3):603\u2013608","journal-title":"J Biol Chem"},{"issue":"4","key":"3958_CR41","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/S0021-9258(17)34190-X","volume":"254","author":"JL Palmer","year":"1979","unstructured":"Palmer JL, Abeles RH (1979) The mechanism of action of S-adenosylhomocysteinase. J Biol Chem 254(4):1217\u20131226","journal-title":"J Biol Chem"},{"issue":"12","key":"3958_CR42","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.10.012","volume":"26","author":"J Zhao","year":"2017","unstructured":"Zhao J, Chen H, Liu N et al (2017) Role of hyperhomocysteinemia and hyperuricemia in pathogenesis of atherosclerosis. J Stroke Cerebrovasc Dis 26(12):2695\u20132699. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2016.10.012","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"3","key":"3958_CR43","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1159\/000368507","volume":"40","author":"H Uedono","year":"2015","unstructured":"Uedono H, Tsuda A, Ishimura E et al (2015) Relationship between serum uric acid levels and intrarenal hemodynamic parameters. Kidney Blood Press Res 40(3):315\u2013322. https:\/\/doi.org\/10.1159\/000368507","journal-title":"Kidney Blood Press Res"},{"issue":"2 Pt 2","key":"3958_CR44","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1161\/hy02t2.102992","volume":"39","author":"N Li","year":"2002","unstructured":"Li N, Chen YF, Zou AP (2002) Implications of hyperhomocysteinemia in glomerular sclerosis in hypertension. Hypertension (Dallas, Tex\u202f: 1979) 39(2 Pt 2):443\u2013448. https:\/\/doi.org\/10.1161\/hy02t2.102992","journal-title":"Hypertension (Dallas, Tex : 1979)"},{"issue":"37","key":"3958_CR45","doi-asserted-by":"publisher","first-page":"e27202","DOI":"10.1097\/md.0000000000027202","volume":"100","author":"PT Liu","year":"2021","unstructured":"Liu PT, Chen JD (2021) Synergistic association of hyperuricemia and hyperhomocysteinemia with chronic kidney disease in middle-aged adults and the elderly population. Medicine 100(37):e27202. https:\/\/doi.org\/10.1097\/md.0000000000027202","journal-title":"Medicine"},{"issue":"10","key":"3958_CR46","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1001\/jama.298.10.1163","volume":"298","author":"RL Jamison","year":"2007","unstructured":"Jamison RL, Hartigan P, Kaufman JS et al (2007) Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial. JAMA 298(10):1163\u20131170. https:\/\/doi.org\/10.1001\/jama.298.10.1163","journal-title":"JAMA"},{"issue":"5","key":"3958_CR47","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.clnu.2012.12.009","volume":"32","author":"X Qin","year":"2013","unstructured":"Qin X, Huo Y, Xie D, Hou F, Xu X, Wang X (2013) Homocysteine-lowering therapy with folic acid is effective in cardiovascular disease prevention in patients with kidney disease: a meta-analysis of randomized controlled trials. Clin Nutr 32(5):722\u2013727. https:\/\/doi.org\/10.1016\/j.clnu.2012.12.009","journal-title":"Clin Nutr"},{"issue":"6","key":"3958_CR48","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1161\/01.Hyp.0000069700.62727.C5","volume":"41","author":"RJ Johnson","year":"2003","unstructured":"Johnson RJ, Kang DH, Feig D et al (2003) Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension (Dallas, Tex: 1979) 41(6):1183\u20131190. https:\/\/doi.org\/10.1161\/01.Hyp.0000069700.62727.C5","journal-title":"Hypertension (Dallas, Tex: 1979)"},{"issue":"1","key":"3958_CR49","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12944-022-01765-0","volume":"21","author":"X Wei","year":"2022","unstructured":"Wei X, Jia X, Liu R et al (2022) Metabolic pathway analysis of hyperuricaemia patients with hyperlipidaemia based on high-throughput mass spectrometry: a case-control study. Lipids Health Dis 21(1):151. https:\/\/doi.org\/10.1186\/s12944-022-01765-0","journal-title":"Lipids Health Dis"},{"issue":"9","key":"3958_CR50","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1007\/s00296-015-3242-0","volume":"35","author":"F Perez-Ruiz","year":"2015","unstructured":"Perez-Ruiz F, Aniel-Quiroga MA, Herrero-Beites AM, Chinchilla SP, Erauskin GG, Merriman T (2015) Renal clearance of uric acid is linked to insulin resistance and lower excretion of sodium in gout patients. Rheumatol Int 35(9):1519\u20131524. https:\/\/doi.org\/10.1007\/s00296-015-3242-0","journal-title":"Rheumatol Int"},{"key":"3958_CR51","doi-asserted-by":"publisher","first-page":"945","DOI":"10.2147\/ijgm.S277957","volume":"13","author":"K Kritmetapak","year":"2020","unstructured":"Kritmetapak K, Charoensri S, Thaopanya R, Pongchaiyakul C (2020) Elevated serum uric acid is associated with rapid decline in kidney function: a 10-year follow-up study. Int J General Med 13:945\u2013953. https:\/\/doi.org\/10.2147\/ijgm.S277957","journal-title":"Int J General Med"},{"key":"3958_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare9101341","author":"HT Le","year":"2021","unstructured":"Le HT, Le TT, Tran NMT et al (2021) Serum uric acid levels and risk of rapid decline of estimated glomerular filtration rate in patients with type 2 diabetes: findings from a 5-year prospective cohort study. Healthcare. https:\/\/doi.org\/10.3390\/healthcare9101341","journal-title":"Healthcare"},{"issue":"40","key":"3958_CR53","doi-asserted-by":"publisher","first-page":"e27420","DOI":"10.1097\/md.0000000000027420","volume":"100","author":"Y Shibata","year":"2021","unstructured":"Shibata Y, Yamazaki M, Kitahara J et al (2021) Changes in serum uric acid levels as a predictor of future decline in renal function in older adults with type 2 diabetes. Medicine 100(40):e27420. https:\/\/doi.org\/10.1097\/md.0000000000027420","journal-title":"Medicine"},{"issue":"6","key":"3958_CR54","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1053\/j.ajkd.2015.05.017","volume":"66","author":"D Sircar","year":"2015","unstructured":"Sircar D, Chatterjee S, Waikhom R et al (2015) Efficacy of febuxostat for slowing the GFR decline in patients with ckd and asymptomatic hyperuricemia: a 6-month, double-blind, randomized, placebo-controlled trial. Am J Kidney Dis 66(6):945\u2013950. https:\/\/doi.org\/10.1053\/j.ajkd.2015.05.017","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"3958_CR55","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1053\/j.ajkd.2018.06.028","volume":"72","author":"K Kimura","year":"2018","unstructured":"Kimura K, Hosoya T, Uchida S et al (2018) Febuxostat therapy for patients with stage 3 CKD and asymptomatic hyperuricemia: a randomized trial. Am J Kidney Dis 72(6):798\u2013810. https:\/\/doi.org\/10.1053\/j.ajkd.2018.06.028","journal-title":"Am J Kidney Dis"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-024-03958-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-024-03958-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-024-03958-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T12:10:23Z","timestamp":1718885423000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-024-03958-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,21]]},"references-count":55,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["3958"],"URL":"https:\/\/doi.org\/10.1007\/s11255-024-03958-1","relation":{},"ISSN":["1573-2584"],"issn-type":[{"type":"electronic","value":"1573-2584"}],"subject":[],"published":{"date-parts":[[2024,2,21]]},"assertion":[{"value":"29 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval was obtained from the Ethics Review Committee of Qingdao University (QYFY WZLL 27994).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}